Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126473491 | 12647349 | 1 | I | 20160730 | 20160812 | 20160812 | EXP | US-SUN PHARMACEUTICAL INDUSTRIES LTD-2016US-121462 | RANBAXY | KATIE LYNNE O^SULLIVAN, MELTEM ZEYTINO GLU, TOMAI-A J YOKES. SEVERE HYPERCALCEMIA EXACERBATED BY EXCESSIVE VITAMIN D SUPPLEMENTATION IN THE SETTING OF PRIMARY HYPERPARATHYROIDISM.. ENDOCR REV. 2014 | 73.00 | YR | F | Y | 0.00000 | 20160812 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126473491 | 12647349 | 1 | PS | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | 50000 U, WEEKLY | U | U | UNK | 40865 | |||||||
126473491 | 12647349 | 2 | SS | Colecalciferol | CHOLECALCIFEROL | 1 | Unknown | 5000 U, DAILY | U | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126473491 | 12647349 | 1 | Product used for unknown indication |
126473491 | 12647349 | 2 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126473491 | 12647349 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126473491 | 12647349 | Hypercalcaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |